Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Multi-Center Study To Evaluate Multiple Doses of NT100 Following IVF In Women With Repeated IVF Failures (Thrive-IVF)

ClinicalTrials.gov ID: NCT01864356

Public ClinicalTrials.gov record NCT01864356. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 25, 2026, 2:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double Blind, Multi-Center, Placebo Controlled Study To Evaluate The Efficacy, Safety, And Tolerability Of Multiple Doses Of NT100 Following IVF In Women With A History Of Repeated IVF Failures (Thrive-IVF)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy, safety and tolerability of multiple doses of subcutaneous NT100 vs placebo following in vitro fertilization (IVF) in women with a history of repeated IVF failures.

Study identification

NCT ID
NCT01864356
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Nora Therapeutics, Inc.
Industry
Enrollment
157 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
21 Years to 38 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2013
Primary completion
Aug 31, 2014
Completion
Aug 31, 2014
Last update posted
Nov 19, 2014

2013 – 2014

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
21
Facility City State ZIP Site status
HRC Fertility Encino California 91436 —
HRC Fertility Newport Beach California 92663 —
HRC Fertility Pasadena California 91105 —
UCSF San Francisco California — —
Reproductive Associates of Delaware Newark Delaware 19713 —
Columbia Fertility Associates Washington D.C. District of Columbia 20037 —
Florida Fertility Institute Clearwater Florida 33759 —
IVF and Fertility Center of Miami Miami Florida 33176 —
Georgia Reproductive Specialists Atlanta Georgia 30342 —
Fertility Centers of Illinois / River North IVF Center Chicago Illinois 60610 —
Fertility Centers of Illinois / Highland Park IVF Center Highland Park Illinois 60035 —
Shady Grove Fertility Rockville Maryland 20850 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Boston IVF Waltham Massachusetts — —
Columbia University New York New York 10032 —
Institute for Reproductive Health Cincinnati Ohio 45209 —
Main Line Fertility Center Bryn Mawr Pennsylvania 19010 —
Center for Assisted Reproduction Bedford Texas 76022 —
Houston Fertility Institute Houston Texas 77063 —
Center of Reproductive Medicine Webster Texas 77598 —
Utah Fertility Center Pleasant Grove Utah 84062 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01864356, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 19, 2014 · Synced Sep 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01864356 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →